TY - JOUR
T1 - Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients
T2 - May 2015
AU - GESIDA/SEIMC Writing Committee
AU - Iribarren, José Antonio
AU - Rubio, Rafael
AU - Aguirrebengoa, Koldo
AU - Arribas, Jose Ramón
AU - Baraia-Etxaburu, Josu
AU - Gutiérrez, Félix
AU - Lopez Bernaldo de Quirós, Juan Carlos
AU - Losa, Juan Emilio
AU - Miró, José Ma
AU - Moreno, Santiago
AU - Pérez Molina, José
AU - Podzamczer, Daniel
AU - Pulido, Federico
AU - Riera, Melchor
AU - Rivero, Antonio
AU - Sanz Moreno, José
AU - Amador, Concha
AU - Antela, Antonio
AU - Arazo, Piedad
AU - Arrizabalaga, Julio
AU - Bachiller, Pablo
AU - Barros, Carlos
AU - Berenguer, Juan
AU - Caylá, Joan
AU - Domingo, Pere
AU - Estrada, Vicente
AU - Knobel, Hernando
AU - Locutura, Jaime
AU - López Aldeguer, José
AU - Llibre, Josep Ma
AU - Lozano, Fernando
AU - Mallolas, Josep
AU - Malmierca, Eduardo
AU - Miralles, Celia
AU - Miralles, Pilar
AU - Muñoz, Agustín
AU - Ocampo, Agustín
AU - Olalla, Julián
AU - Pérez, Inés
AU - Pérez Elías, Ma Jesús
AU - Pérez Arellano, José Luis
AU - Portilla, Joaquín
AU - Ribera, Esteban
AU - Rodríguez, Francisco
AU - Santín, Miguel
AU - Sanz Sanz, Jesús
AU - Téllez, Ma Jesús
AU - Torralba, Miguel
AU - Valencia, Eulalia
AU - Von Wichmann, Miguel Angel
N1 - Publisher Copyright:
© 2016 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica
PY - 2016/10/1
Y1 - 2016/10/1
N2 - Despite the huge advance that antiretroviral therapy represents for the prognosis of infection by the human immunodeficiency virus (HIV), opportunistic infections (OIs) continue to be a cause of morbidity and mortality in HIV-infected patients. OIs often arise because of severe immunosuppression resulting from poor adherence to antiretroviral therapy, failure of antiretroviral therapy, or unawareness of HIV infection by patients whose first clinical manifestation of AIDS is an OI. The present article updates our previous guidelines on the prevention and treatment of various OIs in HIV-infected patients, namely, infections by parasites, fungi, viruses, mycobacteria, and bacteria, as well as imported infections. The article also addresses immune reconstitution inflammatory syndrome.
AB - Despite the huge advance that antiretroviral therapy represents for the prognosis of infection by the human immunodeficiency virus (HIV), opportunistic infections (OIs) continue to be a cause of morbidity and mortality in HIV-infected patients. OIs often arise because of severe immunosuppression resulting from poor adherence to antiretroviral therapy, failure of antiretroviral therapy, or unawareness of HIV infection by patients whose first clinical manifestation of AIDS is an OI. The present article updates our previous guidelines on the prevention and treatment of various OIs in HIV-infected patients, namely, infections by parasites, fungi, viruses, mycobacteria, and bacteria, as well as imported infections. The article also addresses immune reconstitution inflammatory syndrome.
KW - AIDS
KW - HIV infection
KW - Opportunistic infections
UR - http://www.scopus.com/inward/record.url?scp=84960156419&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84960156419&partnerID=8YFLogxK
U2 - 10.1016/j.eimc.2016.02.004
DO - 10.1016/j.eimc.2016.02.004
M3 - Article
C2 - 26976381
AN - SCOPUS:84960156419
SN - 0213-005X
VL - 34
SP - 516.e1-516.e18
JO - Enfermedades Infecciosas y Microbiologia Clinica
JF - Enfermedades Infecciosas y Microbiologia Clinica
IS - 8
ER -